ANA IFA -Anti-Nuclear Antibodies

The Anti-Nuclear Antibodies (ANA) Test by Indirect Immunofluorescence Assay (IFA) using HEp-2 cells is a highly sensitive test for detecting autoimmune disorders. It identifies antibodies targeting cell nuclei, which are associated with conditions like Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome, and other autoimmune diseases.

Why is the ANA-IFA (HEp-2) Test Done?

✅ To Diagnose Autoimmune Disorders, Including:

Systemic Lupus Erythematosus (SLE) (Most common reason for testing)
Sjögren’s Syndrome
Systemic Sclerosis (Scleroderma)
Mixed Connective Tissue Disease (MCTD)
Polymyositis / Dermatomyositis
Rheumatoid Arthritis (RA) with autoimmune overlap

✅ To Identify Patterns of Autoimmune Activity

The HEp-2 cell method detects different ANA patterns, which help in disease classification

✅ To Monitor Disease Activity & Treatment Response

Test Procedure

🩸 Blood Sample Collection:

A blood sample is drawn from a vein
No fasting required
Results available in 3–7 days

🔬 Testing Method:

The serum is applied to HEp-2 cells (human epithelial cells)
If ANA is present, fluorescence patterns are observed under a microscope

Normal Range & Interpretation

ANA Titer	Interpretation
<1:40	Negative (No significant ANA detected)
1:40 – 1:80	Low positive (May be seen in healthy individuals)
>1:80	Positive (May indicate an autoimmune disease)

🔹 A positive ANA test alone does NOT confirm an autoimmune disease; further testing is needed.
🔹 Healthy individuals (especially older adults) may have a low-positive ANA without disease.

Fluorescence Patterns & Their Significance

Pattern	Associated Diseases
Homogeneous	Systemic Lupus Erythematosus (SLE), Drug-induced Lupus
Speckled	Mixed Connective Tissue Disease (MCTD), Sjögren’s Syndrome, SLE
Nucleolar	Systemic Sclerosis (Scleroderma), Polymyositis
Centromere	CREST Syndrome (Limited Systemic Sclerosis)
Cytoplasmic	Autoimmune Liver Diseases, Myositis

What Do Abnormal ANA Levels Mean?

🔴 High ANA Titer (>1:160) Suggests:

SLE (Lupus) – Strong association
Sjögren’s Syndrome
Systemic Sclerosis (Scleroderma)
Polymyositis / Dermatomyositis
Mixed Connective Tissue Disease (MCTD)

🟢 Negative ANA (<1:40):

Autoimmune disease is unlikely
Some lupus patients may still be ANA-negative (rare)

Next Steps If ANA Is Positive?

🔬 Additional Autoimmune Tests for Confirmation:

Anti-dsDNA & Anti-Smith (Sm) Antibodies – Specific for SLE
Anti-Ro (SSA) & Anti-La (SSB) Antibodies – Associated with Sjögren’s Syndrome & Lupus
Anti-Scl-70 & Anti-Centromere Antibodies – Indicate Systemic Sclerosis
Anti-Jo-1 Antibodies – Seen in Polymyositis / Dermatomyositis
Complement Levels (C3, C4) – Low in active autoimmune disease

✅ Treatment Based on Diagnosis:

Lupus & Autoimmune Diseases: Immunosuppressants (Steroids, Hydroxychloroquine, Biologics)
Sjögren’s Syndrome: Symptomatic treatment (Eye drops, Saliva substitutes)
Scleroderma & MCTD: Immune modulation therapy

Key Takeaways

🔹 ANA-IFA (HEp-2) is a highly sensitive test for autoimmune diseases.
🔹 A positive ANA alone does NOT confirm disease; further testing is needed.
🔹 The fluorescence pattern helps determine the specific autoimmune disorder.
🔹 If positive, follow-up with specific antibody tests (dsDNA, Ro/La, Sm, etc.) is essential.